What is an Opioid Treatment Program (OTP)?
An Opioid Treatment Program (OTP) is defined as “a program or practitioner engaged in opioid treatment of individuals with an opioid agonist medication”.
What is an accredited opioid treatment program?
The Substance Abuse and Mental Health Services Administration (SAMHSA) established an accreditation requirement in federal regulations in 2001 to help opioid treatment programs (OTPs) improve the quality of patient care, treatment and services delivered in the OTP setting.
What are the federal guidelines for opioid treatment programs?
Federal Guidelines for Opioid Treatment Programs A manual for the operation of opioid treatment programs (OTPs). This guidance covers patient assessment, treatment planning, medication-assisted treatment (methadone and buprenorphine), overdose and relapse prevention, and recovery care. Apply for Opioid Treatment Program (OTP) Certification
What is office-based opioid treatment?
A: Office-based opioid treatment (OBOT) refers to outpatient treatment services provided in settings other than licensed Opioid Treatment Programs (OTPs). OBOT is provided by DATA 2000-waivered clinicians for patients with opioid use disorder (OUD).
What is the difference between OTP and mat?
While a MMAT Provider offers behavioral health treatment in conjunction with MAT, it is not a requirement that a patient participate. An OTP is a program that requires a patient's adherence to the treatment plan, with the goal of ensuring that the patient has the support necessary to avoid relapse.
What does OTP stand for opioids?
Opioid Treatment Programs (OTPs) provide medication-assisted treatment for people diagnosed with an OUD. OTPs must be certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) and accredited by an independent, SAMHSA-approved accrediting body.
What is an OTP program?
An Opioid Treatment Program (OTP) is defined as “a program or practitioner engaged in opioid treatment of individuals with an opioid agonist medication”.
What does OBOT mean?
Office Based Opioid treatment (OBOT)
What is CPT G2067?
HCPCS. code G2067. Medication assisted treatment, methadone; weekly bundle including dispensing and/or.
How many OTPs are there?
As of March 2021, there were 1,816 OTPs in the United States, and in March 2019, the last year for which data is available, approximately 409,000 patients were receiving methadone treatment at OTPs—the only health care setting where this medication can currently be accessed.
What is methadone OTP?
Opioid Treatment Program Hub. Opioid treatment programs (OTPs) provide medication-assisted treatment (MAT) for persons diagnosed with opioid use disorder using any of three FDA-approved medications: methadone, buprenorphine, and naltrexone.
What does OTP stand for in healthcare?
Medical practitioners. Opioid Treatment Program (OTP) in hospital inpatients.
What is Samhsa program?
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services (HHS) that leads public health efforts to advance the behavioral health of the nation.
Can buprenorphine be diverted?
Like other opioid medications, buprenorphine and methadone are sometimes diverted and misused. However, most data suggest that the majority of buprenorphine and methadone misuse (use without a prescription) is for the purpose of controlling withdrawal and cravings for other opioids and not to get high.
Is methadone an opiod?
Methadone is a synthetic opiate primarily used in the detoxification and maintenance of patients who are dependent on opiates—particularly heroin—and the treatment of patients with chronic, severe pain.
What is Sublocade injection?
SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine- ...
What is an OTP program?
Learn how your Opioid Treatment Program (OTP) can become accredited and certified to treat substance use disorders.
What is OTP accreditation?
Accreditation is a peer-review process that evaluates an OTP against SAMHSA’s opioid treatment standards and the accreditation standards of SAMHSA-approved accrediting bodies. The accreditation process includes onsite visits by specialists with experience in opioid treatment medications and related treatment activities. ...
What happens after an OTP is certified?
After an OTP receives accreditation, they must apply for renewal/recertification of their SAMHSA certification. SAMHSA's OTP Compliance Officers will review all documentation to confirm the OTP is eligible for certification to provide treatment under 42 CFR 8. Programs seeking provisional certification as an OTP must use ...
What is the federal guidelines for opioid treatment programs?
Federal Guidelines for Opioid Treatment Programs#N#A manual for the operation of opioid treatment programs (OTPs). This guidance covers patient assessment, treatment planning, medication-assisted treatment (methadone and buprenorphine), overdose and relapse prevention, and recovery care.
What is required to dispense medication for substance use disorder?
Certification is required to dispense medications for the treatment of substance use disorders. Submit an Opioid Treatment Exception Request. There are federal standards for the administration and management of opioid treatment. Any deviation from the opioid treatment standards requires the submission and approval of an exception request.
COVID-19 and OTPs
Important: Licensing and certification of opioid treatment programs has moved to the Department of Health (DOH) effective July 1, 2018. For more information about licensing and certification, visit the DOH Behavioral Health Agencies page.
How do OTPs work?
OTPs use medications for opioid use disorder (MOUD) — the use of medicines combined with counseling and behavioral therapies — to treat patients diagnosed with opioid use disorders (OUDs).
What do I need to know about certification?
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides oversight of OTPs. For details about certification, visit the OTP certification page on their website.
What is an OTP?
What is an Opioid Treatment Program (OTP)? Opioid Treatment Programs (OTPs) provide medication-assisted treatment for people diagnosed with an OUD. OTPs must be certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) and accredited by an independent, SAMHSA-approved accrediting body.
What is the FDA approved medication for opioid overdose?
New covered services include FDA-approved opioid antagonist medications, specifically naloxone, for emergency treatment of opioid overdose, as well as overdose education provided in conjunction with opioid antagonist medication.
Does Medicaid recoup OTP?
No. Medicaid will recoup payment from a Medicare enrolled OTP back to the date the provider can begin billing Medicare (30 days prior to the effective date of the OTP’s Medicare enrollment), and the OTP will then bill Medicare for those services.
What is an OTP?
OTPs operate under the supervision of a physician and provide counseling and other recovery supports along with medical services related to dosing and treatments on site, which usually require daily visits to the clinic. OBOT programs, however, are provided by clinicians within their regular medical practice.
When was buprenorphine approved?
In 2002, the FDA approved the use of buprenorphine to treat opioid addiction. The Comprehensive Addiction and Recovery Act of 2016 expanded on DATA 2000 to allow nurse practitioners and physician assistants to become eligible for a waiver as well.
What is the medication used in Obot?
In the U.S. today, OBOT uses the medications buprenorphine and/or naltrexone. OBOT programs have fewer requirements and regulations placed on the patient, which can allow easier access to treatment.
What is Obot in medical terms?
A: Office-based opioid treatment (OBOT) refers to outpatient treatment services provided in settings other than licensed Opioid Treatment Programs (OTPs). OBOT is provided by DATA 2000-waivered clinicians for patients with opioid use disorder (OUD).
Overview
Drug overdose deaths have skyrocketed during the COVID-19 pandemic. According to provisional data, there were more than 100,000 fatalities in the 12-month period ending June 2021—a 20.6% increase over the previous 12 months. 1
OTPs should be accessible to all patients in need
Patients with OUD should have access to the medication that works best for them as soon as they are ready to engage in treatment. For some, this means having a nearby OTP so that they can receive methadone. Yet, in many states, particularly in their rural areas, these services are out of reach.
OTPs should provide patient-centered care
People with OUD vary in their goals, how their body responds to medication, and what they need from treatment providers.
OTPs should provide integrated medical and mental health care
People with OUD often have other health problems. One study found that, after “drug overdose and disorder,” the leading causes of death among people with OUD served by a large health system included cardiovascular disease, cancer, and infectious disease.
OTPs should offer services tailored to the populations they serve
Beyond medication, OTPs are required by federal rules to offer counseling, vocational, and educational services.
Conclusion
OTPs’ treatment and services vary widely across the country, and there are many opportunities to expand their reach and improve the quality of services they provide. State policymakers should work to implement these changes to ensure access to quality, patient-centered care for all of their residents.
Endnotes
F. Ahmad, L. Rossen, and P. Sutton, “Provisional Drug Overdose Death Counts,” National Center for Health Statistics, accessed Nov. 6, 2020, https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
